Mannose-sensitive and Gal-Gal binding Escherichia coli pili from recombinant strains. Chemical, functional, and serological properties by unknown
MANNOSE-SENSITIVE  AND  GAL-GAL  BINDING  ESCHERICHIA 
COLI PILI  FROM  RECOMBINANT  STRAINS 
Chemical, Functional, and Serological Properties* 
BY PETER O'HANLEY,  DAVID LARK,* STAFFAN  NORMARK, 
STANLEY  FALKOW, and  GARY  K.  SCHOOLNIK  j! 
From the Medical Service, Palo Alto Veterans Administration Medical Center, and the 
Departments of Medicine and Medical Microbiology, Stanford University School of  Medicine, 
Stanford, California 94305 
Two major classes of chromosomally encoded Escherichia  coli pili  have been 
defined  functionally by  their  receptor  specificities.  Common  pili  are  termed 
"mannose-sensitive" (MS).  They bind Tamm-Horsfall uromucoid and their ag- 
glutination of guinea pig erythrocytes is inhibited by o-mannose.  In  contrast, 
mannose-resistant (MR) pili agglutinate human erythrocytes in the presence of 
D-mannose. Most human pyelonephritis E. coli isolates express MR pili that bind 
neutral glycosphingolipid constituents of uroepithelial cells (1). They contain o- 
Gal p  o~1 ---* 4 D-Gal p 131 and a synthetic analogue of this disaccharide (Syn Gal- 
Gal) inhibits hemagglutination (2). 
Mannose, GaI-Gal, and X  pili may co-exist on the same bacterial strain (3, 4). 
Consequently,  the  pathogenic  significance of functionally distinct pili  may be 
difficult to  assess  with  clinical  isolates.  Therefore,  Hull  et al.  (4)  cloned  two 
distinct E. coli chromosomal fragments that encode mannose or Gat-Gal pili, into 
a nonpiliated K-12 derivative. The functional, serologic, and chemical properties 
of pili prepared from these recombinants is the subject of this report. 
Materials and Methods 
Bacterial Strains 
E. coli J96 (04,  K6), a pyelonephritis isolate,  is hemolytic, colicin  V positive, motile, 
and can simultaneously express  MS and GaI-Gai pili (4). The construction of the two 
recombinant strains, SH48 and HU849, which express MS or Gal-Gal pili, respectively, is 
described in detail elsewhere (4). P678-54 was employed as a hemagglutination-negative 
control. 
Pill Purification 
Pili  from strains J96,  SH48,  and  HU849  were purified from organisms grown on 
trypticase soy agar for 18 h at 37°C according to the method of Brinton (5). After three 
cycles of precipitation and solubilization in the appropriate buffers (5), the HU849 pilus 
preparation  formed a  single protein  band in  SDS-PAGE  according to the method of 
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Laemmli (6). SH48 pili did not enter the stacking gel under these conditions. Instead, the 
pilus filaments were depolymerized before electrophoresis by the addition of HCI to pH 
1.8 according to the method of McMichael and Ou (7), after which two protein bands 
characteristic of MS pili were detected. Negatively stained pilus preparations were shown 
by electron microscopy to be composed of homologous filaments. 
Amino Acid Analysis 
The amino acid compositions of HU849 and SH48 pili were determined after 24-h 
hydrolysis in 5.7 N HCI at 110°C in vacuo on a Durrum model D500 amino acid analyzer. 
Cysteine and methionine were determined as cysteic acid and methionine sulfone, respec- 
tively after performic acid oxidation (8). 
Sequence Analysis 
The amino terminal amino acid sequences of HU849 and SH48 pili were determined 
by automated Edman degradation on a  Beckman Model 890C liquid phase sequencer. 
Each phenylthiohydantoin (Pth) derivative was identified and quantitated by reverse-phase 
high pressure liquid chromatography (HPLC) and confirmed by gas-liquid  chromatogra- 
phy (GLC) and/or thin-layer chromatography (TLC). 
Enzyme-Linked  Immunosorbent  Assay (ELISA) 
Antibody to each pilus preparation was elicited in rabbits by systemic immunization. A 
two-step competitive ELISA (9) was employed to deduce, from the slopes of the inhibition 
curves, the shared antigenicity between the two pilus proteins. 
Receptor Binding Assays 
A. Hemagglutination (HA) was performed with blood group P~ human and guinea pig 
erythrocytes by slide agglutination:  Whole bacteria (2  x  103 to 2  x  10  s CFU/ml) or 
purified  pili  (0.1-1.0  mg/ml)  were  mixed  with  an  equal  volume of a  3%  (vol/vol) 
erythrocyte suspension in phosphate-buffered saline, pH 7.2 (PBS). 
B. Hapten inhibition of hemagglutination (HAI) by carbohydrate receptor analogues was 
performed in PBS by mixing 2% (wt/vol) a  methyl mannoside (a MM) (Sigma Chemical 
Co., St. Louis, MO) or 4% (wt/vol) synthetic D-Gal pal  --~ 4 D-Gal p/3 OR (Syn GaI-Gal) 
with whole bacteria or isolated pili.  The chemical synthesis of the disaccharides D-Gal p 
al  ~  4D-Gal p  /3OR and D-Man p  al  ~  2D-Man p aOR (Syn Man-Man), vide infra, as 
their 8-methoxycarbonyloctyl-glycosides  (R = ---(CH2)s COOCHy) was performed accord- 
ing to the method of Lemieux (10) by Chembiomed Ltd., (Edmonton, Alberta T6G 2G2, 
Canada).  After  preincubation  for  1  h  at  25°C,  an  equal  volume of a  3%  (vol/vol) 
erythrocyte suspension was added and the reactants were gently mixed. 
IS. Latex agglutination (LCA) was employed to define pi[us receptor specificity. Syn Gal- 
Gal or Syn Man-Man was adsorbed to latex beads (Chembiomed Ltd.). Lactose-adsorbed 
latex was used as an agglutination-negative control. Equal volumes of whole bacteria or 
isolated pill were mixed with a  1% (vol/vol) latex suspension in PBS. A11 HA, HAI, and 
LCA assays were read after 5 min. 
Results 
Pilus  Protein  Structure.  Pili  purified  from  strain  J96  were  depolymerized 
according to the method of McMichael and Ou (6) and three proteins of Mr  19 
kdaltons,  17.5 kdaltons, and  17 kdaltons were noted by SDS-PAGE.  When  the 
pili were prepared according to the method of Laemmli (5) without acid depo- 
lymerization, only the  17.5-kdalton  protein  was detected.  HU849  Gal-Gal  pili 
migrated with the 17.5-kdalton protein; SH48 MS pili only entered the gel after 
acid depolymerization and migrated with the  19- and  17-kdaiton proteins. 
The amino acid compositions of the pili  from the recombinant strains  were 
similar (Table I). Two cysteine residues per subunit were detected for both pilus O'HANLEY  ET  AL.  1715 
TABLE  I 
Amino Acid Composition of Mannose-Sensitive (SH48) and Gal-Gal 
Binding (HU849) Pili of the Pyelonephritic E. coli Strain J96 
Amino acid 
Integral number: residues per subunit* 
SH48 (MS)  HU849 (GaI-Gal) 
Ala  35  17 
Val  14  17 
Leu  14  9 
lie  5  6 
Pro  2  5 
Phe  8  7 
Trp  ND*  ND 
Met  i  ND  1 
Asx  18  19 
GIx  16  13 
Lys  4  10 
Arg  2  ND 
His  2  2 
Gly  21  21 
Ser  9  11 
Thr  20  12 
V~ Cys  t  2  2 
Tyr  2  2 
* Based  on  a  mol  wt of  18  kdaltons (SH48  pili) or  17.5  kdaltons (HU849  pili) 
estimated by SDS-PAGE. 
* ND, No amino acid was detected. 
i  Cysteine was analyzed as cysteic acid and methionine as methionine sulfone. 
preparations and  these form an  intra-chain  disulfide bond since no sulfhydryi 
group was detected by amino acid analysis after alkylation of unreduced pili (11). 
The presence of a  disulfide loop has been detected in other E. coli pili (9) and 
may be a conserved feature of the tertiary structure of these proteins. The amino 
acid compositions reported here and elsewhere (9) indicate the presence of one 
methionine  residue  per  Gal-Gal  pilus  subunit.  In  contrast,  MS  pili  lack  this 
residue  (7,  12)  and  cannot  be  intrinsically  labeled  with  [35S]methionine (Paul 
Orndorff, personal communication). 
The amino-terminal amino acid sequences of the pili from the recombinant 
strains  were  determined  through  residue  46  (Table  II).  When  the  cysteine 
residues are aligned,  13 of the first 46 positions (27%) were homologous. The 
amino acid sequences of SH48 MS pili (Table II) and E. coli BAM (9) are identical 
through residue 26. In contrast, only 32% of the first 26 residues of HU849 pili 
and  Gai-Gal  pili  from  the  uropathic  E.  coli strains  3669  and  3048  (9),  are 
homologous. Proline exists within the first 21  residues (Table  II) of the three 
Gal-Gal pili for which N-terminal amino acid sequences are available (9) and may 
have significance for secondary structure  by helix termination or reverse-turn 
nucleation. 
Serologic Properties of Pili.  <5% shared antigenicity was detected between the 
two pilus proteins (Fig.  1); therefore, the homologous regions that exist within 
the N-terminal 46 residues do not specify an immunodominant antigenic deter- 
minant. 
Binding Properties of Whole Bacteria and Isolated Pili.  E. coli strain J96 agglutin- 
ated human and guinea pig erythrocytes and latex particles adsorbed with Syn 
Man-Man and Syn Gal-Gal.  Hapten inhibition of J96 hemagglutination by aMM 
and Syn Gal-Gal was demonstrated (Table III). SH48 agglutinated only guinea 1716  E  COLI  PILl  FROM  RECOMBINANT  STRAINS 
TABLE  II 
Amino Terminal Amino Acid Sequence 
Recombi-  Residue no. 
nant  Receptor 
strain  specificity  1  2  3  4  5  6 
HU849  GaI-Gal*  Ala  Pro  Thr  Ile  Pro  Gin 
SH48  Mannose  --  Ala  Ala  Thr  Thr  Val 
5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 
HU849  Pro  Gin  Gly  Gin  GG~r*  Lys  Val  Thr  Phe  Asn  Gt,~  Thr  Val  Val  Asp 
SH48  Thr  Val  Asn  GI  X  ~  Thr  ~  His  ~  Lys  ~  Glu  ~  V--"ffl  Asn 
20  21  22  23  24  25  ~  27  2-'8-  29  30  31 
HU849  Ala  Pro  Cys  Ser  lie  Ser  Gin  Lys  Ser  Ala  Asp  Gin 
SH48  ~  ~aa  Ala  Cys  Ala  Val  Asp  Ala  Gly  (Thr)  I  Val  Asp 
32  33  34  35  36  37  38  39  40  41  42  43  44  45  46 
HU849  Ser  lie  Asp  Phe  G.,ly  Gin  Leu  Ser  Lys  Ser  Phe  Leu  Glu  Ala  Gly 
SH48  Thr  Val  Gin  Leu  ~  ~  Val  Arg  Thr  Ala  Thr  ~  Ala  Gin  Glu 
* GaI-Gal: D-Gal p a  1 --~ 4D-Gal p/31. 
* Underlined residues are conserved. 
I  Residue identified by reverse-phase high-pressure liquid chromatography of Pth derivative, only. 
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FIGURE  l.  The  antigenic relatedness of GaI-Gal pili  from recombinant strain  HU849  and 
MS pill from recombinant strain SH48  by a  two-step competitive ELISA (15).  (A) Inhibition 
of the binding of GaI-Gal pig antibody to microtiter wells coated with GaI-Gal pill by increasing 
concentrations of soluble Gal-Gal pili (O) or MS pill (A). (B)  Inhibition of the binding of MS 
pill antibody to microtiter wells coated  with  MS pili by increasing concentrations of soluble 
MS pili (A) or Gal-Gal pill (O). 
pig erythrocytes and latex particles adsorbed with Syn Man-Man.  HU849 agglu- 
tinated only human erythrocytes and latex particles adsorbed with Syn Gal-Gal. 
The purified pili exhibited the binding specificities  of the recombinant strain 
from which they were prepared (Table III). Thus, the binding properties of the 
parent strain and both recombinants are conferred by two pilus proteins that are 
genetically, chemically, antigenically, and functionally distinct. O'HANLEY ET AL.  17 17 
TABLE  III 
Agglutinating Properties of E. coli Strains and Isolated Pili 
Agglutinin 
Erythrocyte species: 
Disaccharide adsorbed latex beads: 
Carbohydrate  i 
Bacteria  Human  Guinea  pil~  Syn Gal-Gal  Syn Man-  Lactose 
HA*/HAI*  HA/HAl  Man 
J96  +/Syn GaI-Gal  +/aMM  +  + 
HU849  +/Syn GaI-Gal  -/-  +  - 
SH48  -/-  +/aMM  -  + 
P678-54  -/-  -/-  -  - 
Pilus protein 
HU849  +/Syn GaI-Gal  -/-  +  - 
SH48  -/-  +/aMM  -  + 
* Hemagglutination  of human or guinea  pig erythrocytes:  +  positive;  -  negative.  Minimal  hemagglutinating 
concentrations of bacteria  for human and guinea pig erythrocytes were 5 X 104 CFU/ml and 2.5 x  l0  s CFU/ml, 
respectively. The minimal hemagglutinating concentration of pilus protein for human and guinea pig erythrocytes 
was 250 t~g/ml. 
* Hapten inhibition  of hemagglutination by Syn Gal-Gal (4% wt/vol) or aMM (a methyl mannoside) (2% wt/vol). 
! Agglutination  of latex beads adsorbed with Syn GaI-Gal or Syn Man-Man or Lactose: + positive; -  negative. 
Discussion 
Chromosomal genes that encode MS or GaI-Gal pili have been cloned from an 
uropathic E.  coil strain  and  the recombinants used in  a  murine urinary tract 
infection model (13,  14).  The Gal-Gal piliated recombinant strain attached to 
exfoliated uroepithelial cells in vitro (15) and colonized renal tissue in vivo (13, 
14).  A  vaccine composed of pure GaI-Gal pili  blocked renal colonization and 
invasion  by  the  parent  strain  (14).  In  contrast,  the  MS  recombinant bound 
Tamm-Horsfall  uromucoid,  but  did  not  colonize  the  renal  epithelium  (14). 
Furthermore, a  MS  pilus  vaccine conferred no protection.  Pili  were purified 
from these recombinants and their chemical, functional, and serologic properties 
determined. 
The N-terminal amino acid sequences of MS and Gal-Gal pili exhibit consid- 
erable  homology and  are  highly  homologous with  the  published  N-terminal 
sequences for five MS and five MR pili from other uropathic E. coli (9, 16). Two 
common structural features characterize these sequences. All exhibit the pattern 
-GIy-X1-VaI-X2-Phe-X3-Gly-X4-Val-VaI-Asx-Ala-Xs-Cys-, where the intervening 
residues (X) tend to be charged or polar uncharged; and all appear to possess 
two cysteine residues in disulfide linkage. C-terminal homology between MS and 
MR pili also exists. The HU849 Gal-Gal pilus C-terminal amino acid sequence 
was determined by automated Edman degradation of a tryptic fragment (O'Han- 
ley,  unpublished  observation)  and  aligned  for  maximal  homology  with  the 
published C-terminal sequence of Type IB and IC pili (16, 17). The Gal-Gal and 
MS  sequences are -Phe-Asn-Leu-Thr-Tyr-Gln-COOH  and -Thr-Phe-Asn-Val-Tyr- 
Gln-COOH,  respectively. These structural features suggest that pili arose from 
a  common ancestral gene and  that  the conserved regions are functionally or 
physically critical.  In  contrast,  plasmid-encoded pili  from enteropathic E.  coli 
exhibit no apparent homology with MS or GaI-Gal pili (17) and may therefore 
be evolutionarily unrelated. 
The functional differences between MS and GaI-Gal pili suggest that relatively 
little homology exists in portions of these molecules that encompass the receptor 1718  E COLI P1LI FROM RECOMBINANT STRAINS 
binding domain. Distinct receptor specificities may confer a selective advantage 
in ecologic niches characterized by different host molecules in mucus or on cell 
surfaces. The discovery of chromosomally determined MR pili of "X" specificity 
(3) indicates that the binding repertoire of pili may be extensive. 
The antigenic differences between MS and Gal-Gal pili (Fig.  1) indicate that 
homologous regions of the sequence are immuno-recessive. Unconserved regions 
must, therefore, determine the serologic diversity of these pili.  This may be a 
concomitant of their separate carbohydrate binding specificities if their antigenic 
and  receptor  binding  domains  are  co-extensive.  However,  the  carbohydrate 
binding domains and the antigenic determinants of lectin like proteins appear to 
be structurally dissimilar. The carbohydrate combining site usually consists of an 
hydrophobic cleft in the protein's surface; whereas, antigenic determinants are 
frequently specified by the region of greatest average hydrophilicity. Serologic 
diversity may have resulted from selective pressure imposed by the host immune 
system. Therefore, the immunodominant antigenic determinant and the receptor 
binding domain of E.  coli pili may be chemically and evolutionarily distinct. 
Summary 
Chromosomal genes encoding the MS and Gal-Gal binding properties have 
been cloned into separate recombinants and their respective pili characterized. 
Hapten  inhibition  of hemagglutination  with  synthetic carbohydrate receptor 
analogues and carbohydrate-adsorbed latex agglutination studies indicate that 
GaI-Gal  and  MS  pili  collectively exhibit  the binding properties of the parent 
strain. MS pili migrated in SDS-PAGE with an Mr of 19 kdaltons and 17 kdaltons; 
the Mr of GaI-Gal pili was 17.5 kdaltons. The pili are chemically similar by amino 
acid composition and when the N-terminal cysteines are aligned,  8  of the  13 
residues between positions 9 and 22 are homologous. Further, carboxy-terminal 
sequence homology was inferred from the carboxypeptidase digestion of a  MS 
pili and the sequence of a carboxy-terminal tryptic peptide from Gai-Gal pili. 
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